Basic Information
Basic information for LINC00839-202-33aa
Peptide Name LINC00839-202-33aa
Genome Position chr10:42494459-42494557[+]
Species Human
Peptide Sequence MWVKLCLWLSALKAVFPLIPTLHFISVCLSSFL
Peptide Length 33
Unique No (LINC00839-201-33aa,LINC00839-203-33aa,LINC00839-204-33aa,LINC00839-207-33aa,LINC00839-209-33aa)
Grand Average of Hydropathicity 1.5455
Relative Molecular Mass 4354.19
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000185904;LINC00839
Transcript ID/Name ENST00000429940;LINC00839-202
Transcript Length 2254
Coding Ability 0.3957
DNA Sequence Corresponding to Peptide ATGTGGGTCAAACTCTGTTTGTGGCTCTCAGCTCTCAAGGCTGTTTTCCCCCTGATTCCCACTTTGCACTTTATTTCTGTGTGTTTGTCTTCATTCCTC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :